Top

Published in:

01-12-2003 | Current Opinion

The Doctor’s Duty to the Elderly Patient in Clinical Trials

Authors: Dr Antony Bayer, Mark Fish

Published in: Drugs & Aging | Issue 15/2003

Abstract

The ethical principles of beneficence (or non-maleficence), respect for persons and justice apply to both good medical practice and clinical research. Doctors have a duty to offer to their patients, of all ages, the opportunity to take part in clinical trials and to ensure that research is appropriately designed and conducted.

Barriers to participation of elderly patients in clinical trials include complex protocols with onerous outcome measures, a research focus on aggressive therapies with substantial toxicity, restrictive entry criteria unnecessarily excluding concurrent conditions and medication, patients’ and families’ limited expectations of benefits and lack of financial, logistic and social support.

Participation is encouraged when attitudes of care staff towards research are positive, altruistic motives are acknowledged, approval of family members is gained and protocols are designed for patient rather than staff convenience. Special consideration should be given to ensuring that patient consent is fully informed and freely given.

Elderly patients may have more difficulty comprehending consent information and particular attention should be given to compensating for communication and sensory deficits, improving readability of information sheets and consent forms, and considering the use of innovative consent procedures. Those with cognitive impairment and the institutionalised are vulnerable to exploitation and require special consideration and management.

Department of Health. National Service Framework for Older People. London: Department of Health, 2001. Available from URL: http://www.doh.gov.uk/nsf/olderpeoplemaindoc.htm [Accessed 2003 Sep 4]

Department of Health. Statistical Bulletin 1999/17: statistics of prescriptions dispensed in the community: 1988–1998. London: Department of Health, 1999

Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet 1998; 35: 49–64PubMedCrossRef

Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14: 141–52PubMedCrossRef

Food and Drug Administration, Department of Health and Human Services (USA). International Conference on Harmonisation; guideline on studies in support of special populations: geriatrics: availability. Fed Regist 1994; 59: 33398–400

National Commission for then protection of Human Subjects of Biomedical and Behavioural Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: US Government Printing Office, 1979

Fleischman AR. Developing regulations for research involving adults who lack decision making capacity. Trans Am Clin Climatol Assoc 1999, 110: 131–45PubMed

General Medical Council. Research: the role and responsibilities of doctors. London: General Medical Council, 2002. Available from URL: http://www-gmc-uk.org/globa_sections/search_frameset.htm [Accessed 2003 Sep 4]

Nuremberg Code. Permissible medical experiments, trials of war criminals before the Nuremberg military tribunals under Control Council Law No.10: Nuremberg October 1946–April 1949, Vol 2. Washington, DC: US Government Printing Office, 1946: 181–2

10.

World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Ferney-Voltaire: World Medical Association, 2000. Available from URL: http://www.wma.net/e/policy/b3.htm [Accessed 2003 Sep 4]

11.

National Bioethics Advisory Commission. Ethical and policy issues in research involving human participants. Vol. 1. Rockville (MD): National Bioethics Advisory Commission, 2000. Available from URL: http://www.georgetown.edu/research/nrcbl/nbac/pubs.html. [Accessed 2003 Sep 4]

12.

American Geriatrics Society Ethics and Research Committees. The responsible conduct of research. J Am Geriatr Soc 2001; 49: 1120–2CrossRef

13.

Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315: 1059PubMedCrossRef

14.

Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ 2000; 321: 992–3PubMedCrossRef

15.

Rogers SL, Farlow MR, Doody SR, et al. A 24 week, double blind placebo controlled trial of donepezil in patients with AD. Neurology 1998; 50: 136–45PubMedCrossRef

16.

Rosier M, Anand R, Cicin-Sian A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial. BMJ 1999; 318: 633–58

17.

Weisstub DN, Florez-Arboleda J, Tomossy GF. Establishing the boundaries of ethically permissible research with special populations. Health Law Can 1996; 17: 45–63PubMed

18.

Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ 2002; 325: 415–7PubMedCrossRef

19.

Yastrubetskaya O, Chiu E, O’Connell S. Is good clinical research practice for clinical trials good clinical practice? Int J Geriatr Psychiatry 1997; 12: 227–31PubMedCrossRef

20.

Yusuf S, Held P, Teo KK, et al. Selection of patients for randomised controlled trials: implications of wide or narrow eligibility criteria. Stat Med 1990; 9: 73–86PubMedCrossRef

21.

Britton A, McKee M, Black N, et al. Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy 1999; 4: 112–21PubMed

22.

Bene J, Liston R. The special problems of conducting clinical trials in elderly patients. Rev Clin Gerontol 1997; 7: 1–3CrossRef

23.

Hutchins LF, Unger JM, Crowley JJ, et al. Under-representation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–7PubMedCrossRef

24.

Kemeny M, Muss HB, Kornblith AB, et al. Barriers to participation of older women with breast cancer in clinical trials. Proc Am Soc Clin Oncol 2000; 19: 602a

25.

Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13PubMedCrossRef

26.

Mitchell SL, Sullivan EA, Lipsitz LA. Exclusion of elderly subjects from clinical trials for Parkinson’s disease. Arch Intern Med 1997; 157: 1393–8CrossRef

27.

Bandyopadhyay S, Bayer AJ, O’Mahoney MS. Age and gender bias in statin trials. QJM 2001; 94: 127–32PubMedCrossRef

28.

Trimble EL, Carter CL, Cain D, et al. Representation of older patients in cancer treatment trials. Cancer 1994, 14

29.

Department of Health and Human Services. Medicare coverage issues manual transmittal 126. Washington, DC: US Department of Health and Human Services, 2000. Available from URL: http://www.cms.hhs.gov/manuals/pm_trans/R126CIM.pdf [Accessed 2003 Sep 4]

30.

Monfardini S, Sorio R, Boes GH, et al. Entry and evaluation of elderly patients in European Organisation for research and treatment of Cancer (EORTC) new drug development studies. Cancer 1995; 76: 333–6PubMedCrossRef

31.

The Collaborative Ocular Melanoma Study Group. Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS Report No. 7. Control Clin Trials 2001; 22: 526–37CrossRef

32.

Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist 1990; 30: 100–6PubMedCrossRef

33.

Maine LL, Rodriguez R, Brown J. Geriatric drug testing: who will volunteer?: a descriptive survey. J Geriatr Drug Ther 1988; 2: 63–77CrossRef

34.

Ameer B, Burlingame MB. Difficulties enrolling elderly patients in pharmacokinetic studies. J Geriatr Drug Therapy 1990; 4: 61–7

35.

Cohen-Mansfield J, Kerin P, Pawlson G, et al. Informed consent for research in a nursing home: processes and issues. Gerontologist 1988; 28: 355–9PubMedCrossRef

36.

Sachs GA, Stocking CB, Stern R, et al. Ethical aspects of dementia research: informed consent and proxy consent. Clin Res 1994; 42: 403–12PubMed

37.

Stanley B, Guido J, Stanley M, et al. The elderly patient and informed consent:empiricalfindings. JAMA 1984; 252: 1302–6PubMedCrossRef

38.

Sugarman J, McCrory DC, Hubal RC. Getting meaningful informed consent from older adults: a structured literature review of empirical research. J Am Geriatr Soc 1998; 46: 517–24PubMed

39.

Adams J, Silverman M, Musa D, et al. Recruiting older adults for clinical trials. Control Clin Trials 1997; 18: 14–26PubMedCrossRef

40.

Erlen JA, Sauder RJ, Mellors MP. Incentives in research: ethical issues. Orthop Nurs 1999; 18: 84–7PubMed

41.

Cherniack EP. Informed consent for medical research by the elderly. Exp Aging Res 2002; 28: 183–98PubMedCrossRef

42.

Applebaum PS, Grisso T. Assessing patient’s capacities to consent to treatment. N Engl J Med 1988; 319: 1635–8CrossRef

43.

High DM, Doole MM. Ethical and legal issues in conducting research involving elderly subjects. Behav Sci Law 1995; 13: 319–35PubMedCrossRef

44.

Alexander M. Clinical determination of mental competence: a theory and a retrospective study. Arch Neurol 1988; 45: 23–6PubMedCrossRef

45.

Schindler B, Rachmandi D, Matthews M, et al. Competency and the frontal lobe: the impact of executive dysfunction on decisional capacity. Psychosomatics 1995; 36: 400–4PubMedCrossRef

46.

Marson D, Harreil L. Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer’s disease. Semin Clin Neuropsychiatry 1999; 4: 41–9PubMed

47.

Dymek MP, Atchison P, Harrell L, et al. Competency to consent to medical treatment in cognitively impaired patients with Parkinson’s disease. Neurology 2001; 56: 17–24PubMedCrossRef

48.

CIOMS/WHO International ethical guidelines for biomedical research involving human subjects. Geneva: Council for International Organisations of Medical Societies/World Health Organisation, 2002

49.

Spiro HM. Constraint and consent: on being a patient and a subject. N Engl J Med 1975; 293: 1134–5PubMedCrossRef

50.

Cassel CK. Research in nursing homes: ethical issues. J Am Geriatr Soc 1985; 33: 795–9PubMed

51.

Sachs GA, Rhymes J, Cassel CK. Biomedical and behavioural research in nursing homes: guidelines for ethical investigations. J Am Geriatr Soc 1993; 41: 771–7PubMed

52.

Marson DC, Ingram KK, Cody HA, et al. Assessing the competency of patients with Alzheimer’s disease under different legal standards. Arch Neurol 1995; 52: 949–54PubMedCrossRef

53.

Pucci E, Belardinelli N, Borsetti G, et al. Information and competency for consent to pharmacological clinical trials in Alzheimer disease: an empirical analysis in patients and family caregivers. Alzheimer Dis Assoc Disord 2001; 15: 146–54PubMedCrossRef

54.

CERES. Medical research and you. London: Consumers for Ethics in Research (CERES), 2001

55.

Cassileth BR, Zupkis RV, Sutton-Smith K, et al. Informed consent: why are its goals imperfectly realised? N Engl J Med 1980; 302: 896–900PubMedCrossRef

56.

Featherstone K, Donovan JL. Random allocation or allocation at random?: patient perceptions in a randomised controlled trial. BMJ 1998; 317: 1177–80PubMedCrossRef

57.

Riecken HW, Ravich R. Informed consent to biomedical research in veterans administration hospitals. JAMA 1982; 248: 344–8PubMedCrossRef

58.

Taub HA. Informed consent, memory and age. Gerontologist 1980; 20: 686–90PubMedCrossRef

59.

Taub HA, Baker MT, Sturr JF. Informed consent for research: effects of readability, patient age, and education. J Am Geriatr Soc 1986; 34: 601–6PubMed

60.

Howard JM, DeMets D, the BHAT Research Group. How informed is informed consent?. The BHAT experience. Control Clin Trials 1981; 2: 287–303PubMedCrossRef

61.

LoVerde ME, Prochazka AV, Byyny RL. Research consent forms: continued unreadability and increasing length. J Gen Intern Med 1989; 4: 410–2PubMedCrossRef

62.

Grossman SA, Piantadosi S, Covahey C. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol 1994; 12: 2211–5PubMed

63.

Ratzan RM. Communication and informed consent in clinical geriatrics. Int J Aging Hum Dev 1986; 23: 17–26PubMedCrossRef

64.

Royall DR, Cordes J, Polk M. Executive control and the comprehension of medical information by elderly retirees. Exp Aging Res 1997; 23: 301–13PubMedCrossRef

65.

Schaeffer MH, Krante DS, Wichmann A, et al. The impact of disease severity on the informed consent process in clinical research. Am J Med 1996; 100: 261–8PubMedCrossRef

66.

Bjorn E, Rossel P, Holm S. Can the written information to research subjects be improved?: an empirical study. J Med Ethics 1999; 25: 263–7PubMedCrossRef

67.

Raich PC, Plomer KD, Coyne CA. Literacy, comprehension and informed consent in clinical research. Cancer Invest 2001; 19: 437–45PubMedCrossRef

68.

Philipson SJ, Doyle MA, Nightingale C, et al. Effectiveness of a writing improvement intervention program on the readability of the research informed consent document. J Invest Med 1999; 47: 468–76

69.

Taub HA, Baker MT, Kline GE, et al. Comprehension of informed consent by young-old through old-old volunteers. Exp Aging Res 1987; 13: 173–8PubMedCrossRef

70.

Tymchuk AJ, Ouslander JG, Rahbar B, et al. Medical decisionmaking among elderly people in long-term care. Gerontologist 1988; 28: 59–63PubMedCrossRef

71.

Tymchuk AJ, Ouslander JG, Rader N. Informing the elderly: a comparison of four methods. J Am Geriatr Soc 1986; 24: 818–22

72.

Taub HA, Baker MT. Effect of repeated testing upon comprehension of informed consent materials by elderly volunteers. Exp Aging Res 1983; 9: 135–8PubMedCrossRef

73.

Grisso T, Appelbaum P. Mentally ill and non-mentally ill patients’ abilities to understand informed consent disclosures for medication: preliminary data. Law Hum Behav 1991; 15: 377–88PubMedCrossRef

74.

Olde Rikkert MGM, van der Beckan JHK, ten Have MAMJ, et al. Experienced consent in geriatrics research: a new method to optimize the capacity to consent in frail elderly subjects. J Med Ethics 1997; 23: 271–6CrossRef

75.

Aaronson NK, Visser-Pol E, Leenhouts GH, et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 1996; 14: 984–96PubMed

76.

Christensen K, Haroun A, Schneiderman L, et al. Decision making capacity for informed consent in the older population. Bull Am Acad Psychiatry Law 1995; 23: 353–65PubMed

77.

Hayley DC, Cassel CK, Snyder L, et al. Ethical and legal issues in nursing home care. Arch Intern Med 1996; 156: 249–56PubMedCrossRef

78.

Bonnie LLB. Research with cognitively impaired subjects: unfinished business in the regulation of human research. Arch Gen Psychiatry 1997; 54: 105–11PubMedCrossRef

79.

Brodaty H, Dresser R, Eisner M, et al. Consensus statement: Alzheimer’s disease international and international working group for harmonization of dementia drug guidelines for research involving human subjects with dementia. Alzheimer Dis Assoc Disord 1999; 13: 71–9PubMedCrossRef

80.

Holzer JC, Gansler DA, Moczynski NP, et al. Cognitive functions in the informed consent examination process: a pilot study. J Am Acad Psychiatry Law 1997; 25: 531–40PubMed

81.

Marson DC, Cody HA, Ingram KK, et al. Neuropsychological predictors of competency in AD using a rational reasons legal standard. Arch Neurol 1995; 52: 955–9PubMedCrossRef

82.

Janofsky JS, McCarthy RJ, Folstein MF. The Hopkins competency assessment test: a brief method for evaluating patients’ capacity to give informed consent. Hosp Community Psychiatry 1992; 43: 132–6PubMed

83.

Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv 1997; 48: 1415–9PubMed

84.

Marson DC, Earnst KS, Jamil F, et al. Consistency of physicians’ legal standards and personal judgements of competency in patients with Alzheimer’s disease. J Am Geriatr Soc 2000; 48: 911–8PubMed

85.

Singer EA, Mullner M. Implications of the EU directive on clinical trials for emergency medicine. BMJ 2002; 324: 1169–70PubMedCrossRef

86.

Wichman A, Sandler AL. Research involving critically ill subjects in emergency circumstances: new regulations, new challenges. Neurology 1997; 48: 1151–7PubMedCrossRef

87.

White S, Barua P, O’Mahony MS, et al. Research in older patients: consent and assent. Age Ageing 2002; 31Suppl. 1: 33

88.

Sackett DL. Protection for human subjects in medical research. JAMA 2000; 283: 2388–9PubMed

Title: The Doctor’s Duty to the Elderly Patient in Clinical Trials
Authors: Dr Antony Bayer
Mark Fish
Publication date: 01-12-2003
Publisher: Springer International Publishing
Published in: Drugs & Aging / Issue 15/2003
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI: https://doi.org/10.2165/00002512-200320150-00002

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 15/2003

Galantamine vs Donepezil in the Treatment of Alzheimer’s Disease

Acknowledgement

Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Elderly Men

The Authors Reply

Donepezil in Vascular Dementia

Long-Acting Injectable Antipsychotics in the Elderly

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage